Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    HUTCHMED (China) Limited

    NASDAQ: HCM · Real-Time Price · USD
    16.79
    -0.11 (-0.65%)
    At close: Jun 16, 2025, 3:59 PM
    16.72
    -0.39%
    After-hours: Jun 16, 2025, 07:34 PM EDT
    -0.65%
    Bid 16.65
    Market Cap 2.93B
    Revenue (ttm) 630.2M
    Net Income (ttm) 37.73M
    EPS (ttm) 0.21
    PE Ratio (ttm) 79.93
    Forward PE 29.65
    Analyst Hold
    Ask 16.87
    Volume 43,889
    Avg. Volume (20D) 99,420
    Open 16.79
    Previous Close 16.90
    Day's Range 16.71 - 16.88
    52-Week Range 11.51 - 21.50
    Beta 0.60

    About HCM

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol HCM
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for HCM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    +12.31%
    HUTCHMED shares are trading higher after the compa... Unlock content with Pro Subscription
    3 months ago
    +8.23%
    HUTCHMED shares are trading higher. The company reported FY24 financial results.
    news image

    1 week ago · zacks.com

    Wall Street Analysts See a 68.3% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?

    The mean of analysts' price targets for HUTCHMED (HCM) points to a 68.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

    news image

    4 weeks ago · businesswire.com

    Fragmented HCM systems jeopardize business efficiency, Paycom research reveals

    OKLAHOMA CITY--(BUSINESS WIRE)--Paycom Software, Inc. (NYSE: PAYC) (“Paycom”), a leading provider of comprehensive, cloud-based human capital management software, discovered surveyed businesses rely o...

    news image

    1 month ago · proactiveinvestors.co.uk

    HUTCHMED shares rise 10% as Phase II gastric cancer trial hits key milestone

    Shares in Hutchmed (China) Ltd (AIM:HCM, NASDAQ:HCM, HKG:0013) rose 10% in early trading on Tuesday after the biopharma company announced it had completed patient enrolment for a key phase II trial of...

    news image

    2 months ago · businesswire.com

    Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial

    PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Camzyos--Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial.

    news image

    2 months ago · zacks.com

    3 Internet Delivery Services Stocks in Focus Amid Industry Challenges

    Tariff war, inflationary pressure and still-high interest rates are major concerns for the Zacks Internet - Delivery Services industry. However, efforts to adopt consumer preferences and technological...

    news image

    2 months ago · benzinga.com

    Edgewise Therapeutics Sees Meaningful HCM Treatment Gains With EDG-7500 In Phase 2 Study

    Edgewise Therapeutics, Inc., EWTX on Wednesday reported topline data of EDG-7500 from the Phase 2 CIRRUS-HCM four-week trial in participants with obstructive or nonobstructive Hypertrophic Cardiomyopa...

    news image

    2 months ago · businesswire.com

    AI Becoming Essential to HCM, ISG Says

    STAMFORD, Conn.--(BUSINESS WIRE)---- $III #AI--AI is becoming central to HCM and employee engagement, with two-thirds of enterprises expected to need AI-enabled capabilities by 2027, ISG says.

    2 months ago · youtube.com

    US pharma restrictions won't affect Hutchmed operations, says CEO

    Weiguo Su, CEO of Chinese pharma company HUTCHMED, talks about  the company's latest earnings report, and why it's positioned to be 'sustainably profitable' from this point despite some external chall...

    news image

    2 months ago · seekingalpha.com

    HUTCHMED (China) Limited (HCM) Q4 2024 Earnings Call Transcript

    HUTCHMED (China) Limited (NASDAQ:HCM ) Q4 2024 Earnings Conference Call March 19, 2025 8:00 AM ET Company Participants David Ng - Head:IR Wei-Guo Su - CEO & Chief Scientific Officer Johnny Cheng - CFO...

    news image

    2 months ago · benzinga.com

    Hutchmed's Oncology Revenue Hits $271.5 Million, Rising 65% On Fruzaqla Strength

    On Wednesday, Hutchmed (China) Limited (NASDAQ: ​HCM) reported 2024 earnings of 22 cents per ADS or 4 cents per share, down 59 cents or 12 cents a year ago. Sales fell 25% year over year to $630.20 mi...

    Add to Watchlist